Clinical outcomes in cancer patients with COVID-19.

ABSTRACT:

Background

Early reports on cancer patients with coronavirus disease 2019 (COVID-19) corroborated speculation that cancer patients are at increased risk for becoming infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and developing severe COVID-19. However, cancer patients are a heterogeneous population and their corresponding risk may be different.

Aim

To compare COVID-19 presentation in patients with active malignancy to those with a history of cancer to determine the impact of cancer status on COVID-19 outcomes in the two groups.

Methods and results

Of the 6724 patients who were hospitalized at NYU Langone Health (3/16/20-7/31/20) and tested positive for SARS-CoV-2, 580 had either active cancer (n = 221) or a history of cancer (n = 359). We

SUBMITTER: Sawyers A 

PROVIDER: S-EPMC8420395 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature